Total Temporomandibular Joint Replacement System Post Approval Study
NCT ID: NCT00762944
Last Updated: 2024-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
93 participants
OBSERVATIONAL
2005-09-21
2008-09-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Safety and Performance of Materialise's Patient-specific TMJ System.
NCT06951178
Safety Study of Gintuit™ in Subjects Requiring Socket Grafting
NCT01929954
THE EFFICACY OF RESORBABLE PLATES VERSUS TITANIUM PLATES IN TERMS OF STABILITY IN MANDIBULAR FRACTURES.
NCT05547763
Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant System
NCT02161874
An Observational Clinical Study of the T3 Dental Implant System
NCT05062863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biomet TMJ Replacement System
All patients required total reconstruction of the temporomandibular joint (unilateral or billateral)
Biomet TMJ Replacement System
Total replacement of the temporomandibular joint with a Biomet TMJ Replacement System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biomet TMJ Replacement System
Total replacement of the temporomandibular joint with a Biomet TMJ Replacement System
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Arthritis (osteoarthritis, rheumatoid, traumatic) malignancy Ankylosis functional deformity Avascular necrosis revisions Benign neoplasms fracture Multiple operated joints
2. Patients who are skeletally mature.
3. Patients must have at least one of the following criteria for surgical TMJ treatment.
1. Presence of considerable pain and/or limited function in the joint area.
2. Clinical and imaging evidence consistent with anatomic joint pathology
3. Previous failure of non-surgical treatment/therapy or a failed implant.
4. High probability of patient improvement by surgical treatment.
4. Patients must be able to return for follow-up examinations.
5. Patients without serious compromising general medical conditions.
Exclusion Criteria
2. Patient conditions where there is insufficient quantity or quality of bone to support the device
3. Patients with perforations in the mandibular fossa and/or bony deficiencies in the articular eminence compromising support for the artificial fossa component.
4. Patients with mandibular and/or zygomatic arch screw holes compromising component fixation
5. Patients requiring partial joint reconstruction or other TMJ procedures not listed as an indication.
6. Patients who are NOT skeletally mature.
7. Patients who are incapable or unwilling to follow postoperative care instructions.
8. Patients who are unable to return for follow-up examinations.
9. Patients with severe hyper-functional habits
10. Patients on chronic steroid therapy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zimmer Biomet
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oscar A Gonzalez, MD, DNP
Role: STUDY_CHAIR
Zimmer Biomet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Riley Hospital
Indianapolis, Indiana, United States
Jeffrey S. Topf, D.D.S.
West Bloomfield, Michigan, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
The University of Texas,Southwestern Medical School
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BMET WL 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.